What is the recommended dosage of Doxepin (Doxepin Hydrochloride) for oral capsules?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Doxepin HCl Oral Capsule Dosage Recommendations

For most adult patients, the recommended dosage of Doxepin HCl oral capsules is 75-150 mg/day, with a maximum recommended dose of 300 mg/day. 1

Initial Dosing and Titration

  • For most patients with mild to moderate illness, the recommended starting daily dose is 75 mg 1
  • For patients with very mild symptomatology or emotional symptoms accompanying organic disease, lower doses of 25-50 mg/day may be sufficient 1
  • For more severely ill patients, higher initial doses may be required with subsequent gradual increases up to 300 mg/day if necessary 1
  • Additional therapeutic effect is rarely obtained by exceeding a dose of 300 mg/day 1

Administration Schedule

  • The total daily dosage may be given on a divided or once-a-day schedule 1
  • If using a once-a-day schedule, the maximum recommended dose is 150 mg/day, typically administered at bedtime 1, 2
  • Single daily bedtime dosing has been shown to maintain similar plasma levels as divided dosing, though it may cause more morning sedation 2

Special Considerations

Elderly Patients

  • Lower doses should be used in elderly patients due to potential for decreased renal function 1
  • Elderly patients should be started on low doses and observed closely due to risk of confusion and oversedation 1

Specific Indications

Insomnia

  • For sleep maintenance insomnia, lower doses of 3-6 mg are recommended 3
  • The American Academy of Sleep Medicine suggests doxepin as a treatment for sleep maintenance insomnia at these lower doses 3

Depression with Chronic Pain

  • For patients with chronic pain and depression, dosages up to 200 mg/day have shown efficacy 4
  • Improvements in both pain and depression symptoms have been observed at mean plasma levels of 80 ng/ml 4

Therapeutic Plasma Levels

  • While some sources have suggested a therapeutic range of 150-250 ng/ml (parent drug plus metabolite), this range may be too high 5
  • A working range of 50-250 ng/ml has been proposed based on reassessment of published data 5
  • There is limited correlation between plasma concentrations and clinical improvement 5

Common Side Effects and Precautions

  • Anticholinergic effects: dry mouth, blurred vision, constipation, urinary retention 1
  • CNS effects: drowsiness (most common), confusion, disorientation, hallucinations 1
  • Cardiovascular effects: hypotension, hypertension, tachycardia 1
  • Dosage reduction may be necessary if side effects do not subside or become severe 1
  • Anti-anxiety effects may appear before antidepressant effects 1
  • Optimal antidepressant effect may take two to three weeks to become evident 1

Important Warnings

  • The 150 mg capsule strength is intended for maintenance therapy only and is not recommended for initiation of treatment 1
  • Abrupt cessation after prolonged administration should be avoided; gradual withdrawal is recommended 1
  • Caution is required in patients with cardiovascular disease due to potential cardiac effects 1
  • Overdose can be life-threatening with symptoms including cardiac dysrhythmias, severe hypotension, convulsions, and CNS depression 1

References

Research

Dosage schedule and plasma levels of doxepin and desmethyldoxepin.

The Journal of clinical psychiatry, 1978

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Doxepin's effects on chronic pain and depression: a controlled study.

The Journal of clinical psychiatry, 1984

Research

Doxepin plasma concentrations: is there really a therapeutic range?

Journal of clinical psychopharmacology, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.